GeneDx Holdings (WGS) Stock Price, Quote, News & History | Benzinga

SPY768.20−0.18%QQQ721.48−1.02%BTC/USD81,123.00−0.55%DIA517.15+0.29%GLD380.38+1.17%TLT79.93+1.32%

GeneDx Holdings Corp (WGS) Stock Price, Quote, News & History

WGSNASDAQ

Trade with Public

Trade with Public

$68.61

3.655.62%

Last update: Oct 15, 6:22 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

-

Close

$68.61

Volume / Avg.

189.00 / 720.11K

Day Range

$68.61 - $68.61

52 Wk Range

32.21 - 170.87

Market Cap

$1.93B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

33

Short Interest

36.43%

Days to Cover

5.95

Recent GeneDx Holdings Corp. News

Short Sellers Are All-In on These 10 Stocks — Squeeze Watch List Inside

Ondas, SoundHound AI and CleanSpark are in the top ten most-heavily shorted stocks in the market right now.

Erica Kollmann

Why Is GeneDx Stock Surging Thursday?

GeneDx (WGS) shares rebound 12% as bargain hunters move in following a steep post-earnings sell-off. Is the genetic testing leader oversold?

Akanksha Bakshi

Crude Oil Down 4%; PayPal Shares Fall After Q1 Results

US stocks rise, Nasdaq gains 1%. Dow up 0.57%, Nasdaq up 1.03%, S&P 500 up 0.84%. Materials up 2.1%, financials down 0.2%. PayPal shares fall 9%.

Avi Kapoor

Dow Jumps Over 300 Points; Pfizer Posts Upbeat Earnings

US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower.

Avi Kapoor

GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance. Other stocks falling in pre-market trading.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-48.71M

Investing Cash Flow (TTM)

-38.64M

Financing Cash Flow (TTM)

73.56M

Free Cash Flow (TTM)

-75.80M

Capital Expenditure (TTM)

-27.09M

Net Change in Cash (TTM)

-13.80M

Analyst Trends and Forecast

1

Apr

4

May

2

Jun

2

Aug

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.08B

PE Ratio (TTM)

-

PE Ratio (FWD)

50.76

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.40

PB Ratio (TTM)

8.36

Earnings Yield % (TTM)

-5.30%

Earnings Yield % (FWD)

1.97%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$8.19

Company Debt

Total Debt

$96.84M

LT Debt

$96.84M

LT Debt Issuance (TTM)

$96.70M

LT Debt Repayment (TTM)

-$61.33M

Total Cash

$60.32M

Debt to Equity

0.69

Issuance of Debt (TTM)

$35.37M

Repayment of Debt (TTM)

-$61.33M